Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |